Table 3. In vivo lymphoid progenitor... | American Society of Hematology

Table 3.

In vivo lymphoid progenitor activity of culture-generated BM cells

In vitro treatment, no. of cells injected	No. of donor-origin B cells, × 10⁶
In vitro treatment, no. of cells injected		Bone marrow	Spleen
rIL-7, 1 × 10⁶	12.8 ± 2.0	2.3 ± 0.2
scIL-7/HGFβ, 1 × 10⁶	11.6 ± 4.7	8.2 ± 1.2^*
Normal BM cells, 20 × 10⁶	13.5 ± 5.3	10.7 ± 0.9

In vitro treatment, no. of cells injected	No. of donor-origin B cells, × 10⁶
In vitro treatment, no. of cells injected		Bone marrow	Spleen
rIL-7, 1 × 10⁶	12.8 ± 2.0	2.3 ± 0.2
scIL-7/HGFβ, 1 × 10⁶	11.6 ± 4.7	8.2 ± 1.2^*
Normal BM cells, 20 × 10⁶	13.5 ± 5.3	10.7 ± 0.9

P < .05 between scIL-7/HGFβ– and rIL-7–treated cells